… care and whether it's in the context of a clinical trial or establishing the right coverage and payment rules once we've confirmed evidence of the efficacy of these medications. Accordingly, Medicare and our innovation center cmmi, led by John Brooks and Abe Sutton, are exploring paths to provide wraparound coverage to support patients. as they embark on the recovery. So if you get access to these medications, and ideally over the next several months, the clinical trials, the first phase, will show they're safe enough to be used more broadly. (25:42–25:52)
STATEMENT
Asserts that Medicare and CMMI are exploring ways to provide wraparound coverage for patients.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.